Mutation analysis of BrCA1, BrCA2, and p53 versus soluble HLA class I and class II in a case of familial endometriosis

Fertility and Sterility

Volumn 79, Issue 2, 2003, Pages 445-448

  Goumenou, Anastasia G ^a,b   Vassiliadis, Simon ^a,b   Matalliotakis, Ioannis M ^a,b   Koumantakis, Evgenios G ^a,b   Lembessis, Panayiotis ^a,b   Koutsilieris, Michael ^a,b  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

BrCA1; BrCA2; Mutation analysis; p53; Soluble HLA

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL DISEASE; FEMALE; GENE AMPLIFICATION; GENETIC ANALYSIS; HUMAN; HYSTERECTOMY; LAPAROSCOPY; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS;

EID: 0037305914     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04665-4     Document Type: Letter

References (16)

1. Panidis D.K., Matalliotakis I.M. Subfertility associated with minimal to mild endometriosis. Main mechanisms. J Reprod Med. 42:1998;1034-1042.
2. Arici A., Tazuke I.S., Attar E., Kliman H.J., Olive D.L. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod. 2:1996;40-45.
3. Kennedy S., Mardon H., Barlow D. Familial endometriosis. J Assist Reprod Genet. 12:1995;32-34.
4. Aultman D., Adamashvili I., Yaturu K., Langford M., Gelder F., Gautreaux M., et al. Soluble HLA in human body fluids. Hum Immunol. 60:1999;239-244.
5. Athanassakis I., Ranella A., Vassiliadis S. IFN-gamma facilitates release of class II-loaded intercellular pools in trophoblast cells a novel property independent of protein synthesis . J Interferon Cytokine Res. 20:2000;823-830.
6. Simpson J.L., Malinak L.R., Elias S., Carson S.A., Radvany R.A. HLA association in endometriosis. Am J Obstet Gynecol. 148:1984;395-397.
7. Matalliotakis I.M., Athanassakis I., Goumenou A., Neonaki M.A., Koumantakis E.E., Vassiliadis S., Koumantakis E.E. The possible anti-inflammatory role of circulating human leukocyte antigen levels in women with endometriosis after treatment with danazol and leuprorelin acetate depot. Mediat Inflamm. 10:2001;75-80.
8. lnk4 , GALT, p53, and APOA2 loci in patients with endometriosis. Fertil Steril. 75:2001;160-165.
9. Arvanitis D.A., Goumenou A.G., Matalliotakis I.M., Koumantakis E.E., Spandidos D.A. Low-penetrance genes are associated with increased susceptibility to endometriosis. Fertil Steril. 76:2001;1202-1206.
10. Revised American Fertility Society classification of endometriosis. Fertil Steril. 43:1985;351-356.
11. Friedman L.S., Ostermeyer E.A., Szabo C.I., Dowd P., Lynch E.D., Rowell S.E., King M.C. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet. 8:1994;399-404.
12. Tavtigian S.V., Simard J., Rommens J., Couch F., Shattuck-Eidens D., Neuhausen S., et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet. 12:1996;333-337.
13. Yoshimura I., Kudoh J., Saito S., Tazaki H., Shimizu N. p53 gene mutation in recurrent superficial bladder cancer. J Urol. 153:1995;1711-1715.
14. Baker S.J., Preisinger A.C., Jessup J.M., Paraskeva C., Markowitz S., Willson J.K., et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 50:1990;7717-7722.
15. Simpson J.L., Elias S., Malinak L.R., Buttram V.C. Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol. 137:1980;327-331.
16. Moen M.H., Magnus P. The familial risk of endometriosis. Acta Obstet Gynecol Scand. 72:1993;560-564.